Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1504 participants.
Also called NCT05066620
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,504 participants
- Registry
-
NCT05066620
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05066620. Randomized; quadruple masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2024-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- Chinese herbal medicine FYTF-919
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
- Collaborator
- The George Institute
Record details
- Record id
cardio:ct-nct05066620- Content hash
f80310e6847177d08d75ad15548144022e71200b0759a1d36050d31e4369f1ae